Discover the possibilities of infusion care
Mental health expertise. Personal attention. A next step together.
Jump to: Ketamine · NAD+ · Athletic Recovery · Research
You want more than getting through the day. You want to feel present in your life, connected to the people you love, and able to move toward the things that matter to you.
At Moving Forward Psychiatry & Wellness, those goals guide the conversation. Explore ketamine and NAD+ infusion care with your provider in Parker, Colorado. Learn what the research can tell us, ask your questions, and discover which options deserve a closer look for you.
Let's talk about your options · Explore infusion services & packages
Ketamine: renewed hope for persistent depression
When depression has continued despite medication or therapy, having another treatment option can matter. Clinical trials have found improvements in depressive symptoms within hours to days after IV ketamine, offering the possibility of faster relief for some patients.
The goal is meaningful relief in your life. Your consultation gives us time to understand your history, discuss suitable options, and consider how we would measure progress and plan ongoing care. Response and the duration of benefit vary from person to person.
One-to-one care with a mental health specialist
Your ketamine experience at Moving Forward begins with a psychiatric consultation. During your infusion, a board-certified Psychiatric Mental Health Nurse Practitioner stays with you throughout the session. You have someone present who understands mental health and can give you individual attention.
Explore our ketamine approach · View pricing
IV ketamine for depression is an off-label use, meaning it is not FDA-approved for depression. Esketamine nasal spray (Spravato) is a separate treatment with specific FDA-approved adult depression indications. We can discuss these distinctions during your consultation.
NAD+, mental clarity, and the recovery conversation
If brain fog, attention difficulties, or recovery concerns have led you to explore NAD+, you are in the right place to ask questions. We take those goals seriously and welcome a conversation that considers both your mental health and your broader care.
NAD+ (nicotinamide adenine dinucleotide) is a naturally occurring molecule involved in cellular energy production. Researchers are exploring its clinical potential, including its use in recovery settings. Early reports describe improvements in cravings and emotional symptoms during programs that included NAD+ alongside other infusion ingredients and addiction care.
These observations give researchers questions worth pursuing. They do not yet establish that NAD+ itself improves brain fog, treats ADHD, or prevents relapse. The evidence is preliminary, and lasting benefits and long-term safety are uncertain. Any discussion of NAD+ should sit alongside established ADHD and recovery care, including prescribed medications and appropriate withdrawal management.
Bring your NAD+ questions to your provider · Explore infusion services & packages
NAD+ and athletic recovery
Recovery deserves the same attention as training. NAD+ is a molecule your body naturally uses to produce cellular energy and maintain healthy cell function—processes that make it an intriguing area of research for active adults.
For athletes curious about NAD+ infusions, a personalized consultation offers a chance to explore the science and discuss their recovery goals. Research has not yet established that IV NAD+ speeds muscle recovery or improves athletic performance.
Explore NAD+ infusions with your provider and discuss whether they fit your health goals.
Explore the research
A selection of peer-reviewed studies and recent reviews to help you understand the possibilities and make informed choices.
Ketamine and rapid depression relief
JAMA Psychiatry · 2026 · Shim and colleagues
Across 26 randomized trials involving 1,166 patients, IV ketamine reduced depressive symptoms and suicidal thoughts compared with control treatments during acute care. The findings support its potential for rapid symptom relief; longer-term outcomes remain less established. Reduced suicidal thoughts do not establish suicide prevention.
An important treatment comparison
New England Journal of Medicine · 2023 · Anand and colleagues, ELEKT-D
In an open-label randomized trial of adults with treatment-resistant depression without psychosis, ketamine met the study's standard for being no less effective than electroconvulsive therapy (ECT) for short-term response. This adds evidence for ketamine as an option for selected patients; the treatments have different side effects and suitability considerations.
NAD+ and recovery: early patient observations
Journal of Addiction Psychiatry · 2024; available in PMC in 2025 · Blum and colleagues
In a descriptive series of 50 people receiving addiction care, patients reported improvements in cravings, anxiety, and depression during a combination infusion program containing NAD+. Because there was no randomized comparison group and several treatments were involved, the findings cannot identify NAD+'s individual effect or establish lasting relapse prevention.
Understanding what happens during an NAD+ infusion
Frontiers in Aging Neuroscience · 2019 · Grant and colleagues
This small study in 11 healthy men measured how NAD+ and related compounds changed in blood and urine during and after an infusion. It provides foundational information about NAD+ metabolism, rather than evidence of improved attention, mood, or recovery.
The next chapter in NAD+ research
Frontiers in Aging · 2026 · Alangari and colleagues
This recent review brings together the biological rationale and developing human evidence for IV NAD+ and related compounds. It identifies the need for larger controlled studies to establish reliable clinical benefits, treatment approaches, and long-term safety.
Plan your care with confidence
Your consultation is the place to discuss benefits, risks, medications, medical history, pregnancy or breastfeeding, and what treatment would involve. Ask about monitoring, transportation, follow-up, and how we would decide whether treatment is helping. Continue prescribed ADHD and recovery care unless your treating clinician recommends a change.
Ketamine can cause nausea, sedation, altered perception, and increased blood pressure. Other concerns include breathing problems, misuse or dependence, and bladder or liver problems. Alcohol, opioids, benzodiazepines, and other sedatives can increase risk. NAD+ infusions can cause gastrointestinal symptoms, chest pressure, and increased heart rate; long-term safety is uncertain. Sterile preparation matters: FDA has reported reactions consistent with endotoxin contamination after some injectable NAD+ products. Report symptoms immediately during an infusion.
Ketamine safety information · NAD+ tolerability study · FDA NAD+ notice · Recovery care resources
Your next step can start with a conversation
Tell us what you hope to change. We can review your history, discuss your questions, and explore whether an infusion package fits your needs. You will have space to understand the plan, costs, and next steps before deciding.
Book a consultation with your provider · Explore services & packages · View pricing
This resource is educational and does not replace individual care. If you cannot stay safe, or have severe chest pain, trouble breathing, a seizure, or sudden confusion, call 911 or go to the nearest emergency department. Do not wait for an infusion appointment.